Interpersonal Psychotherapy for Depression After Perinatal Loss
(HeAL Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the effectiveness of interpersonal psychotherapy (IPT) for women experiencing major depression after losing a baby during or soon after pregnancy. IPT aims to improve relationships and social support, aiding in coping with grief and depression. Participants will attend group therapy sessions and some individual sessions, with the option to involve partners or other support people. Women who have experienced perinatal loss and are currently dealing with major depression may be suitable for this study. As an unphased study, this trial provides a unique opportunity to explore new methods for managing grief and depression with professional support.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must have a stable course of antidepressant medication, meaning no changes in the dose for at least 12 weeks before joining the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that interpersonal psychotherapy (IPT) is generally safe and well-tolerated for treating major depression. This therapy has been adapted for women who have experienced the loss of a baby during pregnancy. Studies have found that IPT is both feasible and acceptable for individuals dealing with this type of depression, potentially aiding in better coping.
As a form of talk therapy, IPT lacks the physical side effects that medications might cause. Instead, it enhances personal relationships and communication skills, which can greatly benefit those facing depression.
For those considering joining a trial involving IPT, current evidence suggests it is a safe option for managing major depression after losing a baby during pregnancy.12345Why are researchers excited about this trial?
Researchers are excited about Interpersonal Psychotherapy (IPT) for major depression following perinatal loss because it focuses on enhancing social support, which is crucial during the mourning process. Unlike typical treatments that might involve medication or traditional cognitive therapy, IPT includes group sessions where participants can bring partners or support people to help improve relationship dynamics and reduce conflicts after a loss. This unique approach not only addresses the emotional aspects of depression but also strengthens the social bonds that are vital for recovery.
What evidence suggests that interpersonal psychotherapy might be an effective treatment for depression following perinatal loss?
Research has shown that interpersonal psychotherapy (IPT), one of the treatments studied in this trial, is a promising approach for major depression, especially after losing a baby. Studies have found that IPT reduces symptoms of postpartum depression, which resembles depression after such a loss. This therapy focuses on improving relationships and social support, crucial for those grieving. It has proven practical and well-received by individuals dealing with depression after losing a baby. Additionally, IPT has effectively helped people recover from major depressive disorder (MDD) by enhancing their relationships and communication. Overall, these findings suggest that IPT could be a valuable tool for managing depression in this specific situation.12467
Who Is on the Research Team?
Jennifer E Johnson, PhD
Principal Investigator
Michigan State University
Are You a Good Fit for This Trial?
This trial is for women aged 18-50 in Flint and Detroit, Michigan who have experienced perinatal loss within the last year and are now facing major depression. Participants must speak English, be able to provide contacts for follow-up, have telephone access, and meet specific mental health criteria without recent psychotherapy or unstable medication use.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 12 group sessions and 2 individual sessions of interpersonal psychotherapy (IPT) for major depression following perinatal loss
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 8, 16, and 28 weeks
Open-label extension (optional)
Participants may opt into continuation of treatment long-term
What Are the Treatments Tested in This Trial?
Interventions
- Coping with Depression
- Interpersonal psychotherapy for major depression following perinatal loss
Find a Clinic Near You
Who Is Running the Clinical Trial?
Michigan State University
Lead Sponsor
Women and Infants Hospital of Rhode Island
Collaborator